Related Experiment Video
Updated: May 9, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Pediatric bloodstream infections in Cambodia, 2007 to 2011
Nicole Stoesser1, Catrin E Moore, Joanna M Pocock
1Angkor Hospital for Children, Siem Reap, Cambodia. nicole.stoesser@ndm.ox.ac.uk
Insights
Pediatric bacterial bloodstream infections (BSIs) are common in Cambodia, with significant mortality. Salmonella Typhi and Staphylococcus aureus were leading causes, and antimicrobial resistance is a concern.
Area of Science:
- Pediatrics
- Infectious Diseases
- Microbiology
Background:
- Pediatric bacterial bloodstream infections (BSIs) contribute significantly to global child morbidity and mortality.
- Limited epidemiological data exists for resource-limited regions like Southeast Asia, impacting public health strategies.
Purpose of the Study:
- To investigate the epidemiology and antimicrobial susceptibility of BSIs in children in Siem Reap, Cambodia.
- To analyze demographic, clinical, and outcome data associated with pediatric BSIs.
Main Methods:
- Retrospective analysis of blood cultures from pediatric patients between 2007 and 2011.
- Identification of bacterial pathogens and assessment of antimicrobial susceptibility patterns.
Main Results:
- A BSI incidence of 7.9% was observed, with an increasing trend over the study period.
- Common pathogens included Salmonella Typhi (22.8%), Staphylococcus aureus (12.2%), and Streptococcus pneumoniae (10.0%).
- High mortality (19.0%) was noted, particularly in neonates (36.9%), and associated with meningitis and Klebsiella pneumoniae.
Conclusions:
- BSI poses a significant health challenge in Cambodian children, associated with substantial mortality.
- Further research is required to understand neonatal sepsis, atypical organisms, and pneumococcal disease epidemiology for vaccine strategies.
Background:
Pediatric bacterial bloodstream infections (BSIs) are a major cause of morbidity and mortality worldwide. Epidemiological data from resource-limited settings in southeast Asia, such as Cambodia, are sparse but have important implications for treatment and public health strategies.
Methods:
We retrospectively investigated BSI in children at a pediatric hospital and its satellite clinic in Siem Reap, Cambodia, from January 1, 2007, to July 31, 2011. The range of bacterial pathogens and their antimicrobial susceptibility patterns were analyzed in conjunction with demographic, clinical and outcome data.
Results:
Of 7682 blood cultures with results (99.9% of cultures taken), 606 (7.9%) episodes of BSI were identified in 588 children. The incidence of BSI increased from 14 to 50/1000 admissions (P < 0.001); this was associated with an increased sampling rate. Most BSI were community acquired (89.1%). Common pathogens included Salmonella Typhi (22.8% of all isolates), Staphylococcus aureus (12.2%), Streptococcus pneumoniae (10.0%), Klebsiella pneumoniae (6.4%) and Escherichia coli (6.3%). 21.5% of BSI were caused by a diverse group of uncommon organisms, the majority of which were environmental Gram-negative species. No Listeria monocytogenes or Group B streptococcal BSI were identified. Antimicrobial resistance, particularly among the Enterobacteriaceae, was common. Overall mortality was substantial (19.0%), higher in neonates (36.9%) and independently associated with meningitis/meningoencephalitis and K. pneumoniae infection.
Conclusions:
BSI is a common problem in Cambodian children attending hospital and associated with significant mortality. Further studies are needed to clarify the epidemiology of neonatal sepsis, the contribution of atypical organisms and the epidemiology of pneumococcal disease before the introduction of vaccine.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Distribution
Viral Meningitis
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption